Which Children Are Eligible for Stem Cell Therapy for Autism?
Not every child is a suitable candidate. Here are the inclusion criteria, exclusion criteria, and how eligibility is determined through evaluation.
Why Eligibility Criteria Matter
Stem cell therapy for autism is not appropriate for every child who has received an ASD diagnosis. Rigorous candidacy assessment is not a bureaucratic hurdle — it is fundamental to both safety and the likelihood of meaningful benefit. A clinic that accepts every enquiry without evaluation is a clinic that is not approaching this seriously.
Understanding the general principles behind eligibility helps families know what to expect from the assessment process.
General Inclusion Principles
While every case is assessed individually, the children most likely to benefit from and safely undergo stem cell therapy tend to share several characteristics:
Age range. Most protocols are most effective during periods of high neuroplasticity — typically between 2 and 16 years. Within this range, younger children often (though not always) show more pronounced responses. That said, meaningful responses have been documented across a wider age range.
Confirmed ASD diagnosis. A formal diagnosis from a licensed clinical professional using recognised criteria (DSM-5 or ICD-11) is a baseline requirement.
Neuroinflammatory profile. Children whose profile includes markers of neuroinflammation and immune dysregulation — documented through the pre-evaluation biomarker panel — tend to respond better. This is consistent with the mechanism of action: anti-inflammatory and immune-modulating effects are most relevant where these processes are most active.
Stability. Children should be in a period of relative clinical stability — not in the midst of a major medical event, acute illness, or significant medication change.
Family capacity for follow-up. Stem cell therapy is a process, not a single event. The post-treatment monitoring, QEEG follow-ups and continuation of supportive therapies require family commitment and logistical capacity.
General Exclusion Criteria
The following conditions typically preclude treatment or require very careful individual assessment:
Active, uncontrolled epilepsy. Children with poorly controlled seizures are not appropriate candidates. Well-managed epilepsy with stable medication is evaluated case by case.
Active infection or fever. Treatment cannot safely proceed during an acute illness episode. The immune system must be in a stable state.
Active malignancy or recent oncological treatment. Any history of cancer requires detailed review and is typically a contraindication.
Severe primary immunodeficiency. Conditions involving fundamental immune system compromise require specialist assessment before any cellular therapy.
Recent major surgery or significant blood loss. The recovery window from major procedures needs to be fully resolved before assessment.
Severe coagulation disorders. Bone marrow aspiration requires normal clotting function.
The Evaluation Process
Eligibility is determined through the full pre-evaluation:
1. Initial consultation: family history, diagnosis reports, current profile, questions
2. Biomarker panel: inflammatory cytokines, immune subset profiling, metabolic markers
3. QEEG brain mapping: neurological baseline, identification of specific patterns
4. Case review by the clinical team
5. Family discussion of findings, likely response profile, and recommendation
The evaluation findings — regardless of the treatment recommendation — provide valuable data about your child's neurological and biological profile. Families who are not recommended for treatment at this stage often find the evaluation itself to be informative and directionally useful.
Honest Expectations
Not every eligible child responds to the same degree. Response variability is real and is partially predictable from pre-evaluation data (particular biomarker profiles and QEEG patterns are associated with stronger responses), but cannot be guaranteed. An ethical programme presents this honestly and does not promise specific outcomes.
If your child is in the eligible age range, has a confirmed diagnosis, and you have questions about whether evaluation is appropriate, a free initial consultation with our coordinator is the right starting point.